Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.57 USD | -4.92% | +16.28% | +26.44% |
Apr. 22 | TRxADE HEALTH, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 06 | Top Midday Gainers | MT |
Financials (USD)
Sales 2022 | 11.45M | Sales 2023 | 8.27M | Capitalization | 6.48M |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -17M | EV / Sales 2022 | 0.37 x |
Net Debt 2022 | 450K | Net Debt 2023 | 6.95M | EV / Sales 2023 | 1.62 x |
P/E ratio 2022 |
-0.98
x | P/E ratio 2023 |
-0.22
x | Employees | 8 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 36.01% |
Latest transcript on TRxADE HEALTH, Inc.
1 day | -4.92% | ||
1 week | +16.28% | ||
1 month | +9.32% | ||
3 months | -28.43% | ||
6 months | +10.05% | ||
Current year | +26.44% |
Managers | Title | Age | Since |
---|---|---|---|
Prashant Patel
FOU | Founder | 49 | 05-07-14 |
Chief Executive Officer | 54 | 05-07-14 | |
Jeff Davis
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 05-07-14 | |
Prashant Patel
FOU | Founder | 49 | 05-07-14 |
Donald Fell
BRD | Director/Board Member | 79 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 6.57 | -4.92% | 19,516 |
24-05-30 | 6.91 | +14.59% | 43,594 |
24-05-29 | 6.03 | +2.20% | 9,658 |
24-05-28 | 5.9 | +4.42% | 4,863 |
Delayed Quote Nasdaq, May 31, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+26.44% | 9.24M | |
+27.72% | 426B | |
+31.87% | 276B | |
+6.46% | 92.01B | |
+25.63% | 89.16B | |
+57.95% | 58.86B | |
+11.34% | 45.03B | |
+19.19% | 34.77B | |
-10.48% | 31.93B | |
+12.01% | 28.34B |
- Stock Market
- Equities
- MEDS Stock